2024 Q2 Form 10-Q Financial Statement

#000162828024027254 Filed on June 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q2
Revenue $115.9M $173.0M $123.6M
YoY Change -6.29% -4.06% -15.19%
Cost Of Revenue $91.54M $126.3M $97.70M
YoY Change -6.3% -1.25% -4.18%
Gross Profit $24.31M $46.68M $25.94M
YoY Change -6.26% -10.92% -40.8%
Gross Profit Margin 20.99% 26.98% 20.98%
Selling, General & Admin $45.10M $54.40M $43.20M
YoY Change 4.4% 1.63% 1.15%
% of Gross Profit 185.5% 116.54% 166.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.100M $3.287M $3.214M
YoY Change -3.55% -9.17% -8.38%
% of Gross Profit 12.75% 7.04% 12.39%
Operating Expenses $45.10M $54.40M $43.20M
YoY Change 4.4% 1.63% 1.15%
Operating Profit -$20.79M -$7.720M -$17.26M
YoY Change 20.43% 588.67% -1657.85%
Interest Expense $589.0K $742.0K $172.0K
YoY Change 242.44% 228.32% 588.0%
% of Operating Profit
Other Income/Expense, Net $1.154M $832.0K $1.064M
YoY Change 8.46% -25.58% 26500.0%
Pretax Income -$19.63M -$6.946M -$16.20M
YoY Change 21.22% 231433.33% -1556.56%
Income Tax -$13.00K $13.61M -$4.200M
% Of Pretax Income
Net Earnings -$19.62M -$20.55M -$11.97M
YoY Change 63.95% -6751.13% -1572.08%
Net Earnings / Revenue -16.94% -11.88% -9.68%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.65 -$0.69 -$0.40
COMMON SHARES
Basic Shares Outstanding 29.96M shares 29.80M shares
Diluted Shares Outstanding 29.96M shares 29.80M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $68.02M $95.05M $93.38M
YoY Change -27.16% -16.09% -15.84%
Cash & Equivalents $19.88M $47.03M $43.69M
Short-Term Investments $48.14M $48.02M $49.70M
Other Short-Term Assets $9.742M $11.91M $9.332M
YoY Change 4.39% -34.36% -36.81%
Inventory $78.54M $63.16M $77.18M
Prepaid Expenses
Receivables $7.135M $5.947M $12.97M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $163.4M $176.1M $192.9M
YoY Change -15.26% -13.17% -7.29%
LONG-TERM ASSETS
Property, Plant & Equipment $45.44M $251.9M $49.44M
YoY Change -8.08% -4.4% 6.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.522M $1.598M $1.765M
YoY Change -13.77% -83.43% 40.86%
Total Long-Term Assets $246.6M $253.5M $280.3M
YoY Change -12.04% -7.19% 0.97%
TOTAL ASSETS
Total Short-Term Assets $163.4M $176.1M $192.9M
Total Long-Term Assets $246.6M $253.5M $280.3M
Total Assets $410.0M $429.5M $473.2M
YoY Change -13.35% -9.74% -2.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.01M $14.51M $24.73M
YoY Change -10.99% -9.09% -9.06%
Accrued Expenses $12.71M $74.76M $14.25M
YoY Change -10.81% -0.99% -14.86%
Deferred Revenue $14.13M $14.96M $14.79M
YoY Change -4.5%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $113.4M $104.6M $115.8M
YoY Change -2.02% -3.22% -5.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $278.0K $180.1M $487.0K
YoY Change -42.92% -5.52% -44.15%
Total Long-Term Liabilities $170.6M $180.1M $191.9M
YoY Change -11.11% -5.52% -1.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $113.4M $104.6M $115.8M
Total Long-Term Liabilities $170.6M $180.1M $191.9M
Total Liabilities $284.0M $284.7M $307.7M
YoY Change -7.69% -4.69% -3.17%
SHAREHOLDERS EQUITY
Retained Earnings -$47.58M -$27.96M -$5.438M
YoY Change 775.01% -528.21% -1490.79%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $126.0M $144.9M $165.5M
YoY Change
Total Liabilities & Shareholders Equity $410.0M $429.5M $473.2M
YoY Change -13.35% -9.74% -2.57%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q2
OPERATING ACTIVITIES
Net Income -$19.62M -$20.55M -$11.97M
YoY Change 63.95% -6751.13% -1572.08%
Depreciation, Depletion And Amortization $3.100M $3.287M $3.214M
YoY Change -3.55% -9.17% -8.38%
Cash From Operating Activities -$25.69M $3.725M -$16.20M
YoY Change 58.63% -61.47% -7.74%
INVESTING ACTIVITIES
Capital Expenditures $2.137M $3.415M $4.255M
YoY Change -49.78% 5.86% 63.78%
Acquisitions
YoY Change
Other Investing Activities $527.0K $2.102M -$9.443M
YoY Change -105.58% -122.17% -120.5%
Cash From Investing Activities -$1.610M -$1.313M -$13.70M
YoY Change -88.25% -89.67% -131.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $190.0K $0.00
YoY Change 58.33% -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $153.0K 190.0K $53.00K
YoY Change 188.68% -75.67% -100.65%
NET CHANGE
Cash From Operating Activities -$25.69M 3.725M -$16.20M
Cash From Investing Activities -$1.610M -1.313M -$13.70M
Cash From Financing Activities $153.0K 190.0K $53.00K
Net Change In Cash -$27.15M 2.602M -$29.84M
YoY Change -9.02% -215.13% -268.08%
FREE CASH FLOW
Cash From Operating Activities -$25.69M $3.725M -$16.20M
Capital Expenditures $2.137M $3.415M $4.255M
Free Cash Flow -$27.83M $310.0K -$20.45M
YoY Change 36.07% -95.19% 1.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 tlys Cost Of Goods And Services Sold Excluding Rent
CostOfGoodsAndServicesSoldExcludingRent
90612000 usd
CY2023Q2 tlys Cost Of Goods And Services Sold Excluding Rent
CostOfGoodsAndServicesSoldExcludingRent
96768000 usd
CY2024Q2 tlys Rent Expense Related Party Cost Of Goods Sold
RentExpenseRelatedPartyCostOfGoodsSold
931000 usd
CY2023Q2 tlys Rent Expense Related Party Cost Of Goods Sold
RentExpenseRelatedPartyCostOfGoodsSold
931000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
91543000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
97699000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
24313000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
25938000 usd
CY2024Q2 tlys Selling General And Administrative Expenses Excluding Rent Expense
SellingGeneralAndAdministrativeExpensesExcludingRentExpense
44968000 usd
CY2023Q2 tlys Selling General And Administrative Expenses Excluding Rent Expense
SellingGeneralAndAdministrativeExpensesExcludingRentExpense
43066000 usd
CY2024Q2 tlys Rent Expense Related Party Selling General And Administrative Expenses
RentExpenseRelatedPartySellingGeneralAndAdministrativeExpenses
133000 usd
CY2023Q2 tlys Rent Expense Related Party Selling General And Administrative Expenses
RentExpenseRelatedPartySellingGeneralAndAdministrativeExpenses
133000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
45101000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43199000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-20788000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17261000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1154000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1064000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19634000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16197000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4229000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-19621000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11968000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29962000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29798000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29962000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29798000 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-19621000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11968000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
35000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
116000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
35000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
116000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19586000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11852000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
144869000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
566000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
153000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
35000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
126002000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
176798000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11968000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
522000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
53000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
116000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
165521000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-19621000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11968000 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3095000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3214000 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
566000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
522000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1663000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
154000 usd
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
16000 usd
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-16000 usd
CY2024Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
708000 usd
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
295000 usd
CY2024Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4231000 usd
CY2024Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
822000 usd
CY2023Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3683000 usd
CY2024Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15376000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15065000 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2690000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8162000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7480000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8765000 usd
CY2024Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
14000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
441000 usd
CY2024Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1445000 usd
CY2023Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
873000 usd
CY2024Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2254000 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1616000 usd
CY2024Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-830000 usd
CY2023Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1311000 usd
CY2024Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-126000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-173000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25690000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16195000 usd
CY2024Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
29496000 usd
CY2023Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
24524000 usd
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2137000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4255000 usd
CY2024Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
30000000 usd
CY2023Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15081000 usd
CY2024Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
23000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1610000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13698000 usd
CY2024Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
153000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
53000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
153000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27147000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29840000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47027000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73526000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19880000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43686000 usd
CY2024Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-14000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
724000 usd
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1224000 usd
CY2024Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9886 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
15327 usd
CY2024Q2 us-gaap Number Of Stores
NumberOfStores
246 store
CY2024Q2 tlys Number Of States
NumberOfStates
33 state
CY2024Q2 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Periods</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on the Saturday closest to January 31. References to fiscal 2024 refer to the fiscal year ending February 1, 2025. References to the fiscal quarters or first three months ended May 4, 2024 and April 29, 2023 refer to the thirteen-week periods as of those dates, respectively.</span></div>
CY2024Q2 us-gaap Revenues
Revenues
115856000 usd
CY2023Q2 us-gaap Revenues
Revenues
123637000 usd
CY2024Q2 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2023Q2 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2024Q2 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2023Q2 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2024Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1500000 usd
CY2024Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1300000 usd
CY2023Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1800000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
295539000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
296161000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
291275000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
250097000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
248098000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
241837000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45442000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48063000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49438000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
3100000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
3200000 usd
CY2024Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2024Q2 us-gaap Sublease Income
SubleaseIncome
23400 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
22300 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
53243000 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
71000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
59806000 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
99000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
44721000 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
105000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
36546000 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
0 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
24838000 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
0 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
49363000 usd
CY2024Q2 tlys Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
0 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
268517000 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
275000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
42348000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
226169000 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
275000 usd
CY2024Q2 tlys Lessee Operating Lease Not Yet Commenced Amount
LesseeOperatingLeaseNotYetCommencedAmount
2500000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
17140000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
15753000 usd
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
3714000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
5777000 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
20854000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
21530000 usd
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
18360000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
17300000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0664
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0647
CY2024Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261
CY2024Q2 us-gaap Cash
Cash
1200000 usd
CY2024Q1 us-gaap Cash
Cash
1400000 usd
CY2023Q2 us-gaap Cash
Cash
1200000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
47787000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
355000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48142000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
47583000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
438000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48021000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
49310000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
385000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
49695000 usd
CY2024Q2 tlys Non Cash Impairment Charges
NonCashImpairmentCharges
1700000 usd
CY2023Q2 tlys Non Cash Impairment Charges
NonCashImpairmentCharges
200000 usd
CY2024Q2 tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
3555000 usd
CY2023Q2 tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
356000 usd
CY2024Q2 tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
1892000 usd
CY2023Q2 tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
201000 usd
CY2024Q2 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
43 store
CY2023Q2 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
24 store
CY2024Q2 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
11 store
CY2023Q2 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
6 store
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2447247 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.34
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
511000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.75
CY2024Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
37066 shares
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.13
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
23500 shares
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.28
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
19468 shares
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
13.03
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2878213 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.09
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M18D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
523000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1372963 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.23
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y2M12D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
523000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.68
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.90
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M6D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M12D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.548
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.586
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.043
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.036
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
566000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
522000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5400000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-19621000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11968000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29962000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29798000 shares
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29962000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29798000 shares
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001628280-24-027254-index-headers.html Edgar Link pending
0001628280-24-027254-index.html Edgar Link pending
0001628280-24-027254.txt Edgar Link pending
0001628280-24-027254-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q12024ex311.htm Edgar Link pending
q12024ex312.htm Edgar Link pending
q12024ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlys-20240504.htm Edgar Link pending
tlys-20240504.xsd Edgar Link pending
tlys-20240504_lab.xml Edgar Link unprocessable
tlys-20240504_pre.xml Edgar Link unprocessable
tlys-20240504_htm.xml Edgar Link completed
tlys-20240504_def.xml Edgar Link unprocessable
tlys-20240504_cal.xml Edgar Link unprocessable